Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

The awakening of artistic creativity and Parkinson's disease.

Inzelberg R.

Behav Neurosci. 2013 Apr;127(2):256-61. doi: 10.1037/a0031052. Epub 2013 Jan 14. Review.

PMID:
23316709
2.

Dopaminergic substitution in Parkinson's disease.

Müller T.

Expert Opin Pharmacother. 2002 Oct;3(10):1393-403. Review.

PMID:
12387685
3.

[Levodopa for Parkinson's disease: What have we learned?].

Juri C C, Chaná C P.

Rev Med Chil. 2006 Jul;134(7):893-901. Epub 2006 Aug 29. Review. Spanish.

4.

[Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].

Klivényi P, Vécsei L.

Ideggyogy Sz. 2007 Jan 20;60(1-2):61-4. Review. Hungarian.

PMID:
17432097
5.

Emerging drugs for Parkinson's disease.

Morgan JC, Sethi KD.

Expert Opin Emerg Drugs. 2006 Sep;11(3):403-17. Review.

PMID:
16939381
6.
7.

Treatment of Parkinson's disease. Advances in the pharmacological therapy.

Ghika J.

Eur Neurol. 1996;36(6):396-9. Review. No abstract available.

PMID:
8954312
8.

Levodopa strengths and weaknesses.

Jankovic J.

Neurology. 2002 Feb 26;58(4 Suppl 1):S19-32. Review.

PMID:
11909982
9.

Management of early Parkinson's disease.

Hauser RA, Zesiewicz TA.

Med Clin North Am. 1999 Mar;83(2):393-414, vi. Review.

PMID:
10093585
10.

Factors affecting levodopa effects in Parkinson's disease.

Ogawa N.

Acta Med Okayama. 2000 Jun;54(3):95-101. Review.

11.

[Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].

Kuhn W, Müller T.

Fortschr Neurol Psychiatr. 1997 Aug;65(8):361-74. Review. German.

PMID:
9378449
12.

[Treatment of motor symptoms in Parkinson's disease].

Morís-De la Tassa G, Arias-Rodríguez M.

Rev Neurol. 2009 Jan 23;48 Suppl 1:S27-31. Review. Spanish.

13.

[Optimization of the treatment of Parkinson's disease using dopamine agonists].

Rinne UK.

Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):282-7. Review. Spanish. No abstract available.

PMID:
1687430
14.

Drug therapy of Parkinson's disease. An overview.

Mizuno Y.

Eur Neurol. 1992;32 Suppl 1:3-8. Review.

PMID:
1358614
15.

Clinical practice. Diagnosis and initial management of Parkinson's disease.

Nutt JG, Wooten GF.

N Engl J Med. 2005 Sep 8;353(10):1021-7. Review. No abstract available.

PMID:
16148287
16.

Dopamine agonists.

Tuite P, Ebbitt B.

Semin Neurol. 2001;21(1):9-14. Review.

PMID:
11346030
17.

The safety of dopamine agonists in the treatment of Parkinson's disease.

Bonuccelli U, Ceravolo R.

Expert Opin Drug Saf. 2008 Mar;7(2):111-27. doi: 10.1517/14740338.7.2.111 . Review.

PMID:
18324875
18.

Early Parkinson's disease: what is the best approach to treatment.

Hristova AH, Koller WC.

Drugs Aging. 2000 Sep;17(3):165-81. Review.

PMID:
11043817
19.

Dopamine agonists and neuroprotection in Parkinson's disease.

Olanow CW, Jenner P, Brooks D.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S167-74. Review.

PMID:
9749590
20.

Clinical pharmacology of dopamine agonists in Parkinson's disease.

Lange KW.

Drugs Aging. 1998 Nov;13(5):381-9. Review.

PMID:
9829165

Supplemental Content

Support Center